Maria Gracia-Hernandez

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

Tessa Knox, Eva Sahakian, Debarati Banik et al. · Scientific Reports · 2019 · 162 citations · Full text

Medicine, Oncology, Pharmacology +17

HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer

Debarati Banik, Satish Noonepalle, Melissa Hadley et al. · Cancer Research · 2020 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019

Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra · Frontiers in Pharmacology · 2020 · 55 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Targeting HDAC6 improves anti-CD47 immunotherapy

Maria Gracia-Hernandez, Ashutosh S. Yende, Nithya Gajendran et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition

Satish Noonepalle, Scott Grindrod, Nima Aghdam et al. · Molecular Cancer Therapeutics · 2023 · 21 citations · Full text

Life Sciences, Immunology, Oncology +15